4//SEC Filing
IMCOR PHARMACEUTICAL CO 4
Accession 0001181431-05-010932
CIK 0000761237operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 2:33 PM ET
Size
6.0 KB
Accession
0001181431-05-010932
Insider Transaction Report
Form 4
FLEMING JONATHAN
Director10% Owner
Transactions
- Award
Common Stock
2005-01-10$0.35/sh+50,286$17,600→ 45,011,788 total(indirect: By Oxford Bioscience Partners IV L.P. and MRNA Fund II L.P.)
Footnotes (3)
- [F1]Jonathan Fleming is the general partner of OBP Management IV L.P., which is the general partner of both Oxford Bioscience Partners IV L.P. ("Oxford") and MRNA Fund II L.P. ("MRNA"). As such, Mr. Fleming and OBP Management IV L.P. disclaim beneficial ownership except to the extent of their pecuniary interests therein.
- [F2]Pursuant to Section 2(c) of the Issuer's Registration Rights Agreements dated April 19, 2004 and June 30, 2004, the Issuer issued such shares as liquidated damages in respect of the delayed effectiveness of the Issuer's resale registration statement for the applicable period. Of the 50,286 shares issued on January 10, 2005, 49,786 shares were issued to Oxford and 500 shares were issued to MRNA.
- [F3]Of the 45,011,788 shares held on January 10, 2005, 44,564,652 shares were held by Oxford and 447,136 shares were held by MRNA.
Documents
Issuer
IMCOR PHARMACEUTICAL CO
CIK 0000761237
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000761237
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 2:33 PM ET
- Size
- 6.0 KB